Literature DB >> 4065695

Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.

A B Price, J Levi, J M Dolby, P L Dunscombe, A Smith, J Clark, M L Stephenson.   

Abstract

After the recent successful isolation of spiral organisms from the stomach this paper presents the bacteriological and pathological correlation of gastric antral biopsies from 51 patients endoscopied for upper gastrointestinal symptoms. Campylobacter pyloridis was cultured from 29 patients and seen by either silver staining of the biopsy or scanning electron microscopy in an additional three. The organism was cultured from 23 of the 33 (69%) patients with peptic ulcer disease and from within this group 17 (80%) of the 21 patients with duodenal ulceration. It was cultured only once from the 12 normal biopsies in the series but from 27 of the 38 (71%) biopsies showing gastritis. C pyloridis was also cultured from five out of seven of the 14 endoscopically normal patients, who despite this had biopsy evidence of gastritis. It was the sole organism cultured from 65% of the positive biopsies and scanning electron microscopy invariably revealed it deep to the surface mucus layer. C pyloridis persisted in the three patients with duodenal ulcers after treatment and healing. The findings support the hypothesis that C pyloridis is aetiologically related to gastritis and peptic ulceration though its precise role still remains to be defined.

Entities:  

Mesh:

Year:  1985        PMID: 4065695      PMCID: PMC1432923          DOI: 10.1136/gut.26.11.1183

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Microbes, peptic ulcer, and relapse rates with different drugs.

Authors:  A J McLean; P M Harrison; L L Ioannides-Demos; A J Byrne; P McCarthy; F J Dudley
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

2.  Spiral bacteria of the gastric antrum.

Authors:  C A McNulty; D M Watson
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

3.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Gastric spiral bacteria.

Authors: 
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

5.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

6.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

7.  Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies.

Authors:  D M Jones; A M Lessells; J Eldridge
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

8.  Detection of campylobacter by immunofluorescence in stools and rectal biopsies of patients with diarrhoea.

Authors:  A B Price; J M Dolby; P R Dunscombe; J Stirling
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

9.  Preliminary evaluation of "duodenitis" by endoscopy and biopsy.

Authors:  P B Cotton; A B Price; J R Tighe; J S Beales
Journal:  Br Med J       Date:  1973-08-25

10.  Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.

Authors:  D F Martin; D Hollanders; S J May; M M Ravenscroft; D E Tweedle; J P Miller
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

  10 in total
  56 in total

1.  The British Society of Gastroenterology Diamond Jubilee. March 1997.

Authors: 
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

3.  Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.

Authors:  S Czinn; H Carr; S Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

4.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

6.  Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot.

Authors:  H von Wulffen; J Heesemann; G H Bützow; T Löning; R Laufs
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  High-affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori.

Authors:  T J Trust; P Doig; L Emödy; Z Kienle; T Wadström; P O'Toole
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  14C-urea breath test in C pylori gastritis.

Authors:  E A Rauws; E A Royen; W Langenberg; J V Woensel; A A Vrij; G N Tytgat
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

9.  Seropositivity to Helicobacter pylori: lack of association with length of hospitalization.

Authors:  J G Thoene; M I Burken; R J Hopkins; R G Russell; J G Morris
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.

Authors:  A Ottlecz; J J Romero; S L Hazell; D Y Graham; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.